Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease
- 1 November 2017
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 66 (5) , 1527-1533.e1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial diseaseVascular Medicine, 2016
- The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2016
- Epidemiology of Peripheral Artery DiseaseCirculation Research, 2015
- HDL re-examinedCurrent Opinion in Lipidology, 2015
- Triglycerides and cardiovascular diseaseThe Lancet, 2014
- HDL and cardiovascular diseaseThe Lancet, 2014
- Markers of inflammation in relation to long-term cardiovascular mortality in patients with lower-extremity peripheral arterial diseaseInternational Journal of Cardiology, 2012
- ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery,⁎⁎AAVS/SVS when Guideline initiated, now merged into SVSSociety for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease)JACC, 2006
- Novel Risk Factors for Systemic AtherosclerosisJAMA, 2001
- Major Lower Extremity Amputation in Veterans Affairs Medical CentersAnnals of Vascular Surgery, 2000